We are live on ! Find out more
EMB

Elefante Mark B Portfolio holdings

AUM $182M
1-Year Est. Return 17.71%
This Fund
S&P 500
This Quarter Est. Return
+6.45%
1 Year Est. Return
+17.71%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$156M
AUM Growth
+$23.2M
Cap. Flow
+$16.3M
Cap. Flow %
10.44%
Top 10 Hldgs %
45.39%
Holding
59
New
2
Increased
40
Reduced
9
Closed
3

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$923K
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$835K
3
AMZN icon
Amazon
AMZN
+$752K
4
AAPL icon
Apple
AAPL
+$751K
5
AMAT icon
Applied Materials
AMAT
+$717K

Top Sells

Rank Stock Value
1
BALL icon
Ball Corp
BALL
+$525K
2
ADBE icon
Adobe
ADBE
+$316K
3
DE icon
Deere & Co
DE
+$203K
4
NVO
Novo Nordisk
NVO
+$97.5K
5
PEP icon
PepsiCo
PEP
+$76.4K

Sector Composition

Rank Sector Weight
1 Technology 33.09%
2 Healthcare 17.81%
3 Industrials 13.18%
4 Consumer Discretionary 10.44%
5 Financials 7.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MKC icon
26
McCormick & Company Non-Voting
MKC
$13.7B
$2.32M 1.48%
34,625
+4,780
+16% +$335K
UBER icon
27
Uber
UBER
$143B
$1.71M 1.09%
17,440
+4,745
+37% +$444K
LLY icon
28
Eli Lilly
LLY
$1.02T
$1.66M 1.06%
2,172
+855
+65% +$636K
AXP icon
29
American Express
AXP
$227B
$1.5M 0.96%
4,508
+1,899
+73% +$604K
NEE icon
30
NextEra Energy
NEE
$181B
$1.49M 0.96%
19,781
+5,030
+34% +$368K
CRM icon
31
Salesforce
CRM
$151B
$1.47M 0.94%
6,210
+1,801
+41% +$454K
SCHW
32
Charles Schwab
SCHW
$183B
$1.23M 0.79%
12,925
+5,985
+86% +$568K
AMAT icon
33
Applied Materials
AMAT
$403B
$1.22M 0.78%
5,978
+3,953
+195% +$717K
APH icon
34
Amphenol
APH
$198B
$831K 0.53%
6,715
-150
-2% -$16.5K
NVO
35
Novo Nordisk
NVO
$208B
$825K 0.53%
14,863
-1,665
-10% -$97.5K
ABBV icon
36
AbbVie
ABBV
$443B
$808K 0.52%
3,490
– –
XOM icon
37
ExxonMobil
XOM
$644B
$750K 0.48%
6,650
– –
HON icon
38
Honeywell
HON
$77B
$749K 0.48%
3,776
+1,565
+71% +$327K
V icon
39
Visa
V
$684B
$626K 0.4%
1,835
-140
-7% -$48.5K
COST icon
40
Costco
COST
$422B
$591K 0.38%
638
-10
-2% -$9.59K
CP icon
41
Canadian Pacific Kansas City
CP
$78.1B
$565K 0.36%
7,590
+1,065
+16% +$81.4K
ASML icon
42
ASML
ASML
$626B
$479K 0.31%
+493
New +$388K
PEP icon
43
PepsiCo
PEP
$190B
$410K 0.26%
2,920
-535
-15% -$76.4K
MRK icon
44
Merck
MRK
$322B
$403K 0.26%
4,800
-193
-4% -$15.9K
CRWD icon
45
CrowdStrike
CRWD
$194B
$403K 0.26%
3,284
+1,320
+67% +$150K
UNP icon
46
Union Pacific
UNP
$174B
$355K 0.23%
1,500
– –
GOOG icon
47
Alphabet (Google) Class C
GOOG
$4.36T
$341K 0.22%
1,400
– –
BRK.B icon
48
Berkshire Hathaway Class B
BRK.B
$1.1T
$332K 0.21%
660
+68
+11% +$32.9K
SYK icon
49
Stryker
SYK
$125B
$316K 0.2%
855
-35
-4% -$13.5K
ECL icon
50
Ecolab
ECL
$78.1B
$274K 0.18%
1,000
– –
1
2
3

Similar funds

CIA
Cladis Investment Advisory Billings, Montana $182M AUM 33.3% 1-Year Est. Return
HWM
HFG Wealth Management The Woodlands, Texas $182M AUM 14.4% 1-Year Est. Return
AFS
Anderson Financial Strategies Dayton, Ohio $182M AUM 13.12% 1-Year Est. Return
TFP
Tilia Fiduciary Partners Wilmington, North Carolina $182M AUM 18.85% 1-Year Est. Return
CFG
Capital Financial Group Greenwood Village, Colorado $182M AUM
CFG
Cosner Financial Group Windsor, Colorado $182M AUM 12.93% 1-Year Est. Return
NED
Nancy E. Dempze $182M AUM 16.09% 1-Year Est. Return
RS
R Squared Central, Hong Kong $182M AUM 18.52% 1-Year Est. Return

Elefante Mark B's Q3 2025 Portfolio in Review

As of Q3 2025, Elefante Mark B held 59 positions worth $156M, up 17% from $133M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Elefante Mark B deployed $16.3M of net new capital in Q3 2025, opening 2 new positions and adding to 40 existing holdings. Its largest new stake was ASML: 493 shares worth $479K.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Novo Nordisk, an estimated $97.5K trimmed.

  • Elefante Mark B's largest Q3 2025 buy was ASML: 493 shares worth $479K.
  • Elefante Mark B added most to Microsoft in Q3 2025, an estimated $923K increase.
  • Elefante Mark B's biggest Q3 2025 reduction was Novo Nordisk, cutting an estimated $97.5K.
  • Elefante Mark B fully exited Ball Corp in Q3 2025, selling an estimated $525K.
  • Elefante Mark B's ten largest holdings make up 45% of its $156M portfolio in Q3 2025.
  • Elefante Mark B opened 2 new positions and closed 3 in Q3 2025.
  • Elefante Mark B's portfolio value rose 17% quarter-over-quarter to $156M.

Based on Elefante Mark B's 13F filing for Q3 2025, filed 10 Nov 2025.